NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open $2.92 | Prev. Close $2.98 | Circuit Range N/A |
Day Range $2.92 - $3.15 | Year Range $1.64 - $3.83 | Volume 34,045 |
Average Traded $3.05 |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
21-May-26 | $2.92 | $3.06 | +0.00% |
21-May-26 | $2.92 | $3.06 | +1.16% |
19-May-26 | $3.04 | $3.02 | -2.89% |
18-May-26 | $3.40 | $3.12 | -5.03% |
15-May-26 | $3.31 | $3.28 | +1.08% |
14-May-26 | $3.01 | $3.25 | +9.63% |
13-May-26 | $2.90 | $2.96 | +2.60% |